Cancer Center News

The coalition’s members work to advance a variety of childhood cancer causes by unifying their efforts.

As a designated PTEN Center of Excellence, CHOP offers the highest standards in multidisciplinary care.

Four CHOP researchers are part of a world-class research team that will receive $25 million to study solid tumors in children, funded by Cancer Grand Challenges.

New data on show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.

A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.

CHOP researchers have revealed the molecular mechanics of a cell-surface molecule that is a potential immunotherapy target.

"Of Medicine and Miracles” details the journey of a team of doctors and a family who came together on the leading edge of a cancer cure.

Dr. Peter Phillips, former Section Chief of Neuro-Oncology of our Cancer Center, was recently given the Alex’s Lemonade Stand Foundation (ALSF) Pitcher of Hope Award, which honors someone at CHOP who has gone above and beyond to make an impact on the lives of the children treated in the Oncology Department.

International collaboration aims to ensure more equitable access to transformative personalized cancer therapy.

CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.